Skip to content

Clinical effect analysis of neuroendoscopy combined with Endoport technique in the treatment of hypertensive basal ganglia cerebral hemorrhage

Clinical effect analysis of neuroendoscopy combined with Endoport technique in the treatment of hypertensive basal ganglia cerebral hemorrhage

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098542
Enrollment
Unknown
Registered
2025-03-10
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive intracerebral hemorrhage

Interventions

Endoscope group :None

Sponsors

Liupanshui City People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with hypertensive basal ganglia hemorrhage who were hospitalized and received surgical treatment in the Department of Neurosurgery, Liupanshui People's Hospital from January 2018 to January 2023; (2) The patient met the diagnostic criteria of hypertensive cerebral hemorrhage, and the hemorrhage site was in the basal ganglia, and there was intracranial hematoma formation by CT examination; (3) Blood loss >= 30 mL, and <= 60 mL; (4) The GCS scores of all patients were between 6 and 14, and there was no cerebral hernia. (5) Family members agreed to surgical treatment; (6) There was no obvious coagulation dysfunction and other surgical contraindications.

Exclusion criteria

Exclusion criteria: (1) Postoperative acute obstructive hydrocephalus; (2) Patients with cerebral hemorrhage in ventricles or other parts except basal ganglia; (3) Patients with serious underlying diseases or who are difficult to tolerate general anesthesia craniotomy in preoperative evaluation; (4) Other causes of cerebral hemorrhage cannot be ruled out; (5) Patients whose family members request hospitalization due to economic and other factors; (6) Patients with incomplete case data;

Design outcomes

Primary

MeasureTime frame
Amount of bleeding;Age;Operation time;Intraoperative blood loss;Hematoma clearance rate;Muscle strength recovery;

Countries

China

Contacts

Public ContactLi Xuezheng

Liupanshui City People's Hospital

lxz1479172696@163.com+86 187 7315 4959

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026